Measured Wealth Private Client Group, LLC

Position in INDV — Indivior Pharmaceuticals, Inc.

CIK 1720235 PORTSMOUTH, NH

Back to INDV Full portfolio

Position in INDV

as of Jun 30, 2026 · filed Aug 10, 2026 Compact

Position Value

$549,719

New position

Shares Held

13,398

first reported quarter

Ownership

0.011%

of shares outstanding

% of Portfolio

0.33%

of 13F equity value

Holder Rank

#192

of 334 holders

Holding Since

Jun 2026

1 quarter on record

Voting authority Sole 0% Shared 0% None 100%

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Measured Wealth Private Client Group, LLC holds $841,832 across 6 Drug Manufacturers - Specialty & Generic names. INDV ranks #1 (65.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INDV	Indivior Pharmaceuticals, Inc. This page	13,398	$549,719
2	ELAN	Elanco Animal Health Inc	9,480	$233,302
3	NBIX	Neurocrine Biosciences Inc	140	$23,595
4	HLN	Haleon plc	1,997	$18,632
5	VTRS	Viatris Inc	533	$8,464
6	ZTS	Zoetis Inc.	113	$8,120

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$549,719	13,398	—	Shares	Sole	2026-08-10
No filing history on record for this holder in this stock.

Measured Wealth Private Client Group, LLC

Position in INDV

Position in Drug Manufacturers - Specialty & Generic

All Filings in INDV